Pharma

Your Article Summary

See Latest Articles

Allos Therapeutics Reports Second Quarter 2009 Financial Results
Allos Therapeutics, 08/05/09

Allos Therapeutics, Inc. reported results for the second quarter of 2009. For the three months ended June 2009, the Company reported a net loss of $16.8 million, or per share. This compares to a net loss of $11.8 million, or per share, for the second quarter of 2008. For the six months ended June 2009, the Company reported a net loss of $32.0 million, or per share, compared to a net loss of $23.8 million, or per share, for the same period last year. For the six months ended June 2009, net cash used in operating activities was $25.6 million. Cash, cash equivalents and investments in marketable securities as of June 2009 were $105.2 million.

Today in Financial Reports...keeping you current

Receive free subspecialty "5-minute updates" via email

VA Re-Ups with QuadraMed
HealthDataManagement, 12/18/09

Bristol-Myers Squibb Sets Exchange Ratio of 0.6313 for the Exchange Offer
Bristol Myers-Squibb Company, 12/17/09

Abbott Declares 344th Consecutive Quarterly Dividend
Abbott, 12/15/09

 See all of Financial Reports